Experiment 695579

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

NARINGENIN

Details

PropertyValue
Pharmacology
ESTROGEN RECEPTOR BINDING EFFECT
OrganismEmpty organism
CitationMATTHEWS,J: CELIUS,T: HALGREN,R: ZACHAREWSKI,T:. (2000). DIFFERENTIAL ESTROGEN RECEPTOR BINDING OF ESTROGENIC SUBSTANCES: A SPECIES COMPARISON.. 74(4)
Amount utilized
Compound isolated
DiseaseVS.GST-H-ER-ALPHA-DEF FUSION PROTEIN.
Dose amount100.0 MICROMOLS
Number6
Qualitative resultWEAK ACTIVITY
Dose expressionIC50